145 related articles for article (PubMed ID: 20646367)
1. The role of anti-cyclic citrullinated peptide antibody in periodontal disease.
Ballini A; Tetè S; Scattarella A; Cantore S; Mastrangelo F; Papa F; Nardi GM; Perillo L; Crincoli V; Gherlone E; Grassi FR
Int J Immunopathol Pharmacol; 2010; 23(2):677-81. PubMed ID: 20646367
[TBL] [Abstract][Full Text] [Related]
2. Porphyromonas gingivalis may play an important role in the pathogenesis of periodontitis-associated rheumatoid arthritis.
Liao F; Li Z; Wang Y; Shi B; Gong Z; Cheng X
Med Hypotheses; 2009 Jun; 72(6):732-5. PubMed ID: 19246161
[TBL] [Abstract][Full Text] [Related]
3. Defining the role of Porphyromonas gingivalis peptidylarginine deiminase (PPAD) in rheumatoid arthritis through the study of PPAD biology.
Konig MF; Paracha AS; Moni M; Bingham CO; Andrade F
Ann Rheum Dis; 2015 Nov; 74(11):2054-61. PubMed ID: 24864075
[TBL] [Abstract][Full Text] [Related]
4. Expression of anti-Porphyromonas gingivalis peptidylarginine deiminase immunoglobulin G and peptidylarginine deiminase-4 in patients with rheumatoid arthritis and periodontitis.
Shimada A; Kobayashi T; Ito S; Okada M; Murasawa A; Nakazono K; Yoshie H
J Periodontal Res; 2016 Feb; 51(1):103-11. PubMed ID: 26094771
[TBL] [Abstract][Full Text] [Related]
5. The amount of citrullinated proteins in synovial tissue is related to serum anti-cyclic citrullinated peptide (anti-CCP) antibody levels.
Olivares-Martínez E; Hernández-Ramírez DF; Núñez-Álvarez CA; Cabral AR; Llorente L
Clin Rheumatol; 2016 Jan; 35(1):55-61. PubMed ID: 26255191
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients.
Snir O; Widhe M; Hermansson M; von Spee C; Lindberg J; Hensen S; Lundberg K; Engström A; Venables PJ; Toes RE; Holmdahl R; Klareskog L; Malmström V
Arthritis Rheum; 2010 Jan; 62(1):44-52. PubMed ID: 20039432
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis.
Matsui T; Shimada K; Ozawa N; Hayakawa H; Hagiwara F; Nakayama H; Sugii S; Ozawa Y; Tohma S
J Rheumatol; 2006 Dec; 33(12):2390-7. PubMed ID: 16924694
[TBL] [Abstract][Full Text] [Related]
8. Association of levels of antibodies against citrullinated cyclic peptides and citrullinated α-enolase in chronic and aggressive periodontitis as a risk factor of Rheumatoid arthritis: a case control study.
Reichert S; Schlumberger W; Dähnrich C; Hornig N; Altermann W; Schaller HG; Schulz S
J Transl Med; 2015 Aug; 13():283. PubMed ID: 26319714
[TBL] [Abstract][Full Text] [Related]
9. Autoantibodies against citrullinated histone H3 in rheumatoid arthritis and periodontitis patients.
Janssen KMJ; de Smit MJ; Withaar C; Brouwer E; van Winkelhoff AJ; Vissink A; Westra J
J Clin Periodontol; 2017 Jun; 44(6):577-584. PubMed ID: 28370244
[TBL] [Abstract][Full Text] [Related]
10. Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides.
Mathsson L; Mullazehi M; Wick MC; Sjöberg O; van Vollenhoven R; Klareskog L; Rönnelid J
Arthritis Rheum; 2008 Jan; 58(1):36-45. PubMed ID: 18163519
[TBL] [Abstract][Full Text] [Related]
11. Periodontal health status, Porphyromonas gingivalis and anti-cyclic citrullinated peptide antibodies among rheumatoid arthritis patients.
Wan Jiun T; Taib H; Majdiah Wan Mohamad W; Mohamad S; Syamimee Wan Ghazali W
Int Immunopharmacol; 2023 Nov; 124(Pt B):110940. PubMed ID: 37722261
[TBL] [Abstract][Full Text] [Related]
12. Association between anti-Porphyromonas gingivalis or anti-α-enolase antibody and severity of periodontitis or rheumatoid arthritis (RA) disease activity in RA.
Lee JY; Choi IA; Kim JH; Kim KH; Lee EY; Lee EB; Lee YM; Song YW
BMC Musculoskelet Disord; 2015 Aug; 16():190. PubMed ID: 26265263
[TBL] [Abstract][Full Text] [Related]
13. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles.
Snir O; Widhe M; von Spee C; Lindberg J; Padyukov L; Lundberg K; Engström A; Venables PJ; Lundeberg J; Holmdahl R; Klareskog L; Malmström V
Ann Rheum Dis; 2009 May; 68(5):736-43. PubMed ID: 18635594
[TBL] [Abstract][Full Text] [Related]
14. Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis.
Low JM; Chauhan AK; Kietz DA; Daud U; Pepmueller PH; Moore TL
J Rheumatol; 2004 Sep; 31(9):1829-33. PubMed ID: 15338508
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of anti-cyclic citrullinated Peptide antibody in patients with rheumatoid arthritis.
Zeng X; Ai M; Tian X; Gan X; Shi Y; Song Q; Tang F
J Rheumatol; 2003 Jul; 30(7):1451-5. PubMed ID: 12858440
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: an Italian multicentric study and review of the literature.
Bartoloni E; Alunno A; Bistoni O; Bizzaro N; Migliorini P; Morozzi G; Doria A; Mathieu A; Lotzniker M; Allegri F; Riccieri V; Alpini C; Gabrielli A; Tampoia M; Gerli R;
Autoimmun Rev; 2012 Sep; 11(11):815-20. PubMed ID: 22394488
[TBL] [Abstract][Full Text] [Related]
17. [Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis].
Us D; Gülmez D; Hasçelik G
Mikrobiyol Bul; 2003; 37(2-3):163-70. PubMed ID: 14593899
[TBL] [Abstract][Full Text] [Related]
18. Associations of HLA-DRB1 alleles with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in northern east part of Turkey.
Uçar F; Çapkin E; Karkucak M; Yücel B; Sönmez M; Alver A; Kaklikkaya N; Tosun M; Alemdaroğlu E; Solak M
Int J Rheum Dis; 2012 Dec; 15(6):538-45. PubMed ID: 23253237
[TBL] [Abstract][Full Text] [Related]
19. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
[TBL] [Abstract][Full Text] [Related]
20. Role of anti cyclic citrullinated peptide antibodies in erosive disease in patients with rheumatoid arthritis.
Shankar S; Grover R; Handa R
Indian J Med Res; 2006 Dec; 124(6):689-96. PubMed ID: 17287557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
